[title missed]

DOI: 10.12201/bmr.202507.00044

•  

  Abstract: [abstract missed]

  Key words: ; 

  Submit time: 14 July 2025

  Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
• html

• 图表

• 王馨雨, ZHANG Shujuan. Research progress of GLP-2 in non-alcoholic fatty liver disease. 2025. doi: 10.12201/bmr.202502.00018

  JIA Chen, GONG Yan, HAN Yijing, JIANG Jianan, LIU Weizheng, ZHANG Daxu, LU Wenping. Correlation between psychological stress and metabolic-associated fatty liver disease. 2022. doi: 10.12201/bmr.202204.00003

  NIU Xiao Shan. Advances in pharmacological studies of NF-κB involved in the regulation of nonalcoholic fatty liver disease. 2024. doi: 10.12201/bmr.202410.00006

  Chen Zhiyun. Effects of common environmental pollutants on non-alcoholic fatty liver disease. 2025. doi: 10.12201/bmr.202506.00049

  Li Xue, Fei Yue, Xu Xiahong. Exploring the relationship between serum ferritin and metabolic-associated fatty liver disease in adolescents based on NHANES database. 2025. doi: 10.12201/bmr.202503.00012

  Shen Zhe-jun, Zhu Guan-lin, Ye Fan, Yang Lian, Li Ming. Research Progress on the Impact of Dietary Fiber on Bone Metabolism through Short-Chain Fatty Acids. 2025. doi: 10.12201/bmr.202504.00008

  Zhenghaijuan, NiuXiaohan. Research Progress of CCR and metabolic syndrome and its related diseases. 2025. doi: 10.12201/bmr.202501.00048

  Zhang zhenwen. Effects of SGLT2 inhibitors on the metabolic syndrome and its components. 2025. doi: 10.12201/bmr.202503.00002

  李洛华. . 2025. doi: 10.12201/bmr.202506.00031

  Li Mingyuan, Zhang Xinyi, Wang Lingtai. Clinical Experience of Professor Wang Lingtai in Treating Chronic Liver Diseases with the. 2025. doi: 10.12201/bmr.202504.00020

• ID	Submit time	Number	Download
  1	2025-03-21	bmr.202507.00044V1	Download

• Public  Anonymous  To author only Submit Comments